There were no significant differences between the IL-37 dominant group and the IL-18 dominant group in demographics, AOSD disease course, incidence of disease flares, use of immune-modulating drugs at high disease activity status, and re-flare rate after low disease activity status. The gene discussed is IL18; the disease is adult-onset Still disease.